Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Share-based Compensation (2017 - 2021)

Selectis Health's Share-based Compensation history spans 5 years, with the latest figure at -$250.0 for Q4 2021.

  • For Q4 2021, Share-based Compensation changed N/A year-over-year to -$250.0; the TTM value through Dec 2021 reached -$250.0, up 99.55%, while the annual FY2023 figure was $624.0, N/A changed from the prior year.
  • Share-based Compensation for Q4 2021 was -$250.0 at Selectis Health, up from -$134134.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $228001.0 in Q3 2017 and bottomed at -$134134.0 in Q4 2019.
  • The 4-year median for Share-based Compensation is $81346.0 (2018), against an average of $77727.8.
  • The largest annual shift saw Share-based Compensation surged 1201.74% in 2018 before it crashed 264.89% in 2019.
  • A 4-year view of Share-based Compensation shows it stood at $6249.0 in 2017, then soared by 1201.74% to $81346.0 in 2018, then plummeted by 264.89% to -$134134.0 in 2019, then soared by 99.81% to -$250.0 in 2021.
  • Per Business Quant, the three most recent readings for GBCS's Share-based Compensation are -$250.0 (Q4 2021), -$134134.0 (Q4 2019), and $79155.0 (Q3 2019).